Research progress on liquid biopsy in pancreatic cancer

Abstract

Li Zhijian, He De. Research progress on liquid biopsy in pancreatic cancer[J]. Journal of International Oncology, 2018, 45(3): 180-182.

［1］ Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017［J］. CA Cancer J Clin, 2017, 67(1): 7-30. DOI: 10.3322/caac.21387. ［2］ Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States［J］. Cancer Res, 2014, 74(11): 29132921. DOI: 10.1158/00085472.CAN140155. ［3］ Seufferlein T, Mayerle J. Pancreatic cancer in 2015: precision medicine in pancreatic cancer—fact or fiction?［J］. Nat Rev Gastroenterol Hepatol, 2016, 13(2): 74-75. DOI: 10.1038/nrgastro.2015.215. ［4］ Millner LM, Strotman LN. The future of precision medicine in oncology［J］. Clin Lab Med, 2016, 36(3): 557-573. DOI: 10.1016/j.cll.2016.05.003. ［5］ Koprowski H, Steplewski Z, Mitchell K, et al. Colorectal carcinoma antigens detected by hybridoma antibodies［J］. Somatic Cell Genet, 1979, 5(6): 957-971. ［6］ Zhang Q, Chen S, Zeng L, et al. New developments in the early diagnosis of pancreatic cancer［J］. Expert Rev Gastroenterol Hepatol, 2017, 11(2): 149-156. DOI: 10.1080/17474124.2017.1271323. ［7］ Poruk KE, Gay DZ, Brown K, et al. The clinical utility of CA 199 in pancreatic adenocarcinoma: diagnostic and prognostic updates［J］. Curr Mol Med, 2013, 13(3): 340-351. ［8］ Chang JC, Kundranda M. Novel diagnostic and predictive biomarkers in pancreatic adenocarcinoma［J］. Int J Mol Sci, 2017, 18(3): E667. DOI: 10.3390/ijms18030667. ［9］ Kim YJ, Koh HK, Chie EK, et al. Change in carbohydrate antigen 199 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy［J］. Int J Clin Oncol, 2017, 22(6): 1069-1075. DOI: 10.1007/s10147-017-1129. ［11］ Kulemann B, Pitman MB, Liss AS, et al. Circulating tumor cells found in patients with localized and advanced pancreatic cancer［J］. Pancreas, 2015, 44(4): 547-550. DOI: 10.1097/MPA.0000000000000324. ［12］ Liu H, Sun B, Wang S, et al. Circulating tumor cells as a biomarker in pancreatic ductal adenocarcinoma［J］. Cell Physiol Biochem, 2017, 42(1): 373-382. DOI: 10.1159/000477481. ［13］ Ankeny JS, Court CM, Hou S, et al. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer［J］. Br J Cancer, 2016, 114(12): 1367-1375. DOI: 10.1038/bjc.2016.121. ［14］ Tien YW, Kuo HC, Ho BI, et al. A high circulating tumor cell count in portal vein predicts liver metastasis from periampullary or pancreatic cancer: a high portal enous CTC count predicts liver metastases［J］. Medicine (Baltimore), 2016, 95(16): e3407. DOI: 10.1097/MD.0000000000003407. ［15］ Arnoletti JP, Zhu X, Almodovar AJ, et al. Portal venous blood circulation supports immunosuppressive environment and pancreatic cancer circulating tumor cell activation［J］. Pancreas, 2017, 46(1): 116-123. DOI: 10.1097/MPA.0000000000000667. ［16］ Poruk KE, Valero 3rd, Saunders T, et al. Circulating tumor cell phenotype predicts recurrence and survival in pancreatic adenocarcinoma［J］. Ann Surg, 2016, 264(6): 1073-1081. DOI: 10.1097/SLA.0000000000001600. ［17］ Mandel P, Metais P. Les acides nucleiques du plasma sanguin chez I′homme［J］. Cr Acad Sci Paris, 1948, 142(3-4): 241-243. ［18］高芃, 李金明. 循环肿瘤DNA与肿瘤精准治疗［J］. 实用医院临床杂志, 2016, 13(3): 16. DOI: 10.3969/j.issn.16726170.2016.03.001. ［19］ Henriksen SD, Madsen PH, Larsen AC, et al. Cellfree DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma［J］. Clin Epigenetics, 2016, 8: 117. DOI: 10.1186/s1347801602862. ［20］ Henriksen SD, Madsen PH, Larsen AC, et al. Promoter hypermethylation in plasmaderived cellfree DNA as a prognostic marker for pancreatic adenocarcinoma staging［J］. Int J Cancer, 2017, 141(12): 24892497. DOI: 10.1002/ijc.31024. ［21］ Creemers A, Krausz S, Strijker M, et al. Clinical value of ctDNA in upperGI cancers: a systematic review and metaanalysis［J］. Biochim Biophys Acta, 2017, 1868(2): 394-403. DOI: 10.1016/j.bbcan.2017.08.002. ［22］ Singh N, Gupta S, Pandey RM, et al. High levels of cellfree circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival［J］. Cancer Invest, 2015, 33(3): 78-85. DOI: 10.3109/07357907.2014.1001894. ［23］ Pietrasz D, Pécuchet N, Garlan F, et al. Plasma circulating tumor DNA in pancreatic cancer patients is a prognostic marker［J］. Clin Cancer Res, 2017, 23(1): 116-123. DOI: 10.1158/1078-0432.CCR-16-0806. ［24］ Pan BT, Teng K, Wu C, et al. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes［J］. J Cell Biol, 1985, 101(3): 942948. ［25］ Steinbichler TB, Dudás J, Riechelmann H, et al. The role of exosomes in cancer metastasis［J］. Semin Cancer Biol, 2017, 44: 170-181. DOI: 10.1016/j.semcancer.2017.02.006. ［26］ Whiteside TL. Tumorderived exosomes and their role in cancer progression［J］. Adv Clin Chem, 2016, 74: 103-141. DOI: 10.1016/bs.acc.2015.12.005. ［27］ Melo SA, Luecke LB, Kahlert C, et al. Glypican1 identifies cancer exosomes and detects early pancreatic cancer［J］. Nature, 2015, 523(7559): 177-182. DOI: 10.1038/nature14581. ［28］ Lai X, Wang M, Mcelyea SD, et al. A microRNA signature in circulating exosomes is superior to exosomal glypican1 levels for diagnosing pancreatic cancer［J］. Cancer Lett, 2017, 393: 86-93. DOI: 10.1016/j.canlet.2017.02.019.

[1]	Liu Bohan, Huang Junxing.Research progress of liquid biopsy technology in esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(2): 105-108.
[2]	Huang Zhen, Chen Yongshun.Research progress of circulating tumor DNA in the diagnosis and treatment of hepatocellular carcinoma[J]. Journal of International Oncology, 2024, 51(1): 59-64.
[3]	Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei.Current status of research on exosomes in malignancies[J]. Journal of International Oncology, 2023, 50(8): 484-488.
[4]	Kui Guoju, Huang Jiangbin, Zhang Wenhua, Yang Limin.Effect of regional lymph node diameter on postoperative recurrence in pancreatic cancer patients[J]. Journal of International Oncology, 2023, 50(10): 608-613.
[5]	Li Hongyu, Wu Xinlin.Exosomes and liver metastasis of colorectal cancer[J]. Journal of International Oncology, 2022, 49(12): 749-753.
[6]	Wang Wenhao, Sun Xirui, Liu Jin, Sun Xiumei.Role of cancer-associated fibroblasts in the development and progression of breast cancer[J]. Journal of International Oncology, 2022, 49(10): 615-618.
[7]	Zhang Wanchen, Xu Jiajie, Zhang Lizhuo, Ge Minghua.Clinical significance of exosomal-circRNA in tumor diagnosis and treatment[J]. Journal of International Oncology, 2021, 48(9): 549-552.
[8]	Zhuang Weitao, Qiao Guibin.Research and application of liquid biopsy based on epigenetic markers in the diagnosis and treatment of solid tumors[J]. Journal of International Oncology, 2021, 48(6): 358-361.
[9]	Yan Zhiying, Mao Yifeng, Zhu Yingwei, Xu Kequn.Role of heterogeneity of cancer-associated fibroblasts in targeted therapy of pancreatic cancer[J]. Journal of International Oncology, 2021, 48(5): 308-312.
[10]	Zhong Yang, He Miao, Liu Zhi, Chen Jianyu, Zhang Guangnian, Qin Long, Li Ting, Li Jianshui.Effects of Ophiopogon D combined with cyclooxygenase-2 silencing on proliferation, migration and invasion of human pancreatic cancer BxPC-3 cells[J]. Journal of International Oncology, 2021, 48(10): 583-590.
[11]	Li Keke, Kong Panpan, Yi Chao, Wang Xiyan, Yan Dong.Expression of lymphoid enhancer factor-1 in pancreatic ductal adenocarcinoma and its effect on prognosis[J]. Journal of International Oncology, 2021, 48(10): 608-613.
[12]	Chen Xiaoxu, Yu Yang, Zhang Tianxue.A prognostic risk assessment model for pancreatic cancer established based on immune-related lncRNAs[J]. Journal of International Oncology, 2020, 47(8): 472-479.
[13]	Du Mingli, Li Guixiang, Wu Wenjuan, Zhao Lei.Application of circulating tumor DNA in targeted therapy and immunotherapy of metastatic melanoma[J]. Journal of International Oncology, 2020, 47(6): 381-384.
[14]	Tian Linghan, Zhu Ling, Liu Xin, Ye Jingwen, He Jiahui, Wang Xicai.Level of peripheral blood circulating tumor cells in lung cancer patients detected by CI-101 and its clinical significance[J]. Journal of International Oncology, 2020, 47(4): 199-204.
[15]	Tian Chunfang, Sha Dan.Zinc finger proteins and digestive system cancers[J]. Journal of International Oncology, 2020, 47(2): 115-118.

Research progress on liquid biopsy in pancreatic cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments